Efficacy of eculizumab in refractory life-threatening warm autoimmune hemolytic anemia associated with chronic myelomonocytic leukemia.
Résumé
We report a case of refractory life-threatening warm autoimmune hemolytic anemia (wAIHA) associated with chronic myelomono-cytic leukemia (CMML) for which all conventional treatments had failed. The use of eculizumab allowed controlling hemolysis and resulted in transfusion independence. These data support the use of eculizumab in refractory wAIHA.
Domaines
Hématologie
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...